{"nct_id":"NCT03867084","title":"Safety and Efficacy of Pembrolizumab (MK-3475) Versus Placebo as Adjuvant Therapy in Participants With Hepatocellular Carcinoma (HCC) and Complete Radiological Response After Surgical Resection or Local Ablation (MK-3475-937 / KEYNOTE-937)","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-08","start_date":"2019-05-28","start_date_type":"ACTUAL","primary_completion_date":"2025-03-20","primary_completion_date_type":"ACTUAL","completion_date":"2025-09-30","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["MRK"]}